Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.00    -0.50 (-0.14%)
Bid:
351.00
Ask:
356.00
Spread: 5.00 (1.425%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

23 Jan 2026 11:36

RNS Number : 1901Q
Caledonia Investments PLC
23 January 2026
 

 

Caledonia Investments plc

 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the UK Market Abuse Regulation ("MAR") of the following transactions in its ordinary shares of 0.5p ("Shares") involving one of its directors, Mathew Masters.

 

On 21 January 2026, 136,830 Shares were transferred to Mr Masters under the Caledonia Investments 2020 Performance Share Scheme at nil cost. The Shares were sourced from The Caledonia 2024 Employee Benefit Trust ("EBT"). 

 

On the same date, Mr Masters sold 64,500 Shares back to the EBT to meet the tax liability due. All Shares were sold at 363.75p per Share. He retained 72,330 Shares.

 

Following the above transactions, Mr Masters' total interests in Shares are as follows: 

 

Description

Number of Shares

Percentage of voting rights

Beneficial

743,780

0.1427%

Non-beneficial

nil

n/a

Performance share scheme awards

851,310

0.1633%

Deferred bonus plan awards

36,520

0.0070%

Shares held under the Caledonia Investments Share Incentive Plan

754

0.0001%

 

Further information required by MAR in relation to these transactions is set out in the appendix below.

 

Enquiries:

Alex Pollard

Senior Assistant Company Secretary

Tel: + 44 20 7802 8080

 

23 January 2026

APPENDIX

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Mathew Simon Dexter Masters

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 0.5p shares

 

 

 

GB00BTNQ8K38

b)

 

Nature of the transaction

 

 

Exercise of Caledonia Investments 2020 Performance Share Scheme ("2020 PSS") awards

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£0.00

136,830

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A (single transaction)

e)

 

Date of the transaction

 

21 January 2026

f)

Place of the transaction

London - outside a trading venue

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 0.5p shares

 

 

 

GB00BTNQ8K38

b)

 

Nature of the transaction

 

 

Partial sale of shares to meet tax liability arising from 2020 PSS exercise

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£3.6375

64,500

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A (single transaction)

e)

 

Date of the transaction

 

21 January 2026

f)

Place of the transaction

XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBGDBSXDDGLX
Date   Source Headline
30th Mar 20162:05 pmRNSTransaction in Own Shares
23rd Mar 201611:54 amRNSDirector/PDMR Shareholding
16th Mar 20164:42 pmRNSDirector/PDMR Shareholding
8th Mar 20163:58 pmRNSDirectorate Change
4th Mar 20169:20 amRNSNet Asset Value(s)
24th Feb 20167:00 amRNSDividend Declaration
22nd Feb 20169:45 amRNSHome Member State Disclosure
4th Feb 20169:41 amRNSNet Asset Value(s)
18th Jan 20162:07 pmRNSDirector/PDMR Shareholding
7th Jan 20162:34 pmRNSInterim Management Statement
7th Jan 20162:23 pmRNSNet Asset Value(s)
4th Jan 20169:49 amRNSBlocklisting Interim Review
21st Dec 20157:00 amRNSAcquisition
8th Dec 20158:14 amRNSHalf Yearly Report
7th Dec 20159:08 amRNSNet Asset Value(s)
19th Nov 20157:00 amRNSHalf Yearly Report
9th Nov 20159:28 amRNSNet Asset Value(s)
26th Oct 20157:00 amRNSAcquisition
7th Oct 20152:20 pmRNSNet Asset Value(s)
30th Sep 20155:26 pmRNSTransaction in Own Shares
29th Sep 20154:18 pmRNSDirector/PDMR Shareholding
28th Sep 20158:12 amRNSDisposal
7th Sep 20153:20 pmRNSNet Asset Value(s)
7th Sep 201512:40 pmRNSAcquisition
1st Sep 201512:45 pmRNSChange of Registered Office
7th Aug 20159:26 amRNSNet Asset Value(s)
29th Jul 201511:32 amRNSForm 8.3 - Quintain Estates & Development
23rd Jul 20154:47 pmRNSDirector/PDMR Shareholding
23rd Jul 20152:04 pmRNSDirector/PDMR Shareholding
16th Jul 201512:49 pmRNSResult of AGM
6th Jul 20153:08 pmRNSInterim Management Statement
6th Jul 20153:07 pmRNSNet Asset Value(s)
1st Jul 20151:09 pmRNSDirector/PDMR Shareholding
1st Jul 20159:45 amRNSBlocklisting Interim Review
26th Jun 20153:42 pmRNSDirector/PDMR Shareholding
22nd Jun 20157:00 amRNSAcquisition
16th Jun 201510:24 amRNSAnnual Financial Report
4th Jun 20151:55 pmRNSNet Asset Value(s)
27th May 20157:00 amRNSFinal Results
11th May 20152:38 pmRNSHolding(s) in Company
11th May 20159:22 amRNSNet Asset Value(s)
30th Apr 201510:30 amRNSDirector Declaration
17th Apr 20153:51 pmRNSHolding(s) in Company
16th Apr 20154:10 pmRNSHolding(s) in Company
15th Apr 20159:15 amRNSHolding(s) in Company
14th Apr 20152:47 pmRNSHolding(s) in Company
14th Apr 20159:38 amRNSDirector Declaration
10th Apr 201512:30 pmRNSHolding(s) in Company
10th Apr 20159:12 amRNSNet Asset Value(s)
1st Apr 20152:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.